ViVita Technologies Awarded $1.5M NIH Grant to Translate Biomaterials with Blueprints for Regeneration

Grant Supports Evaluation of the BARE Patch™ for FDA 510(k) Clearance Application in Vascular Patch and IDE Application in Heart Valve Indications DAVIS, Calif., Sept. 13, 2022 /PRNewswire/ — ViVita Technologies, Inc. (www.vivitatechnologies.com), a life science startup developing…